Timing of maintenance phenytoin therapy after intravenous loading dose
- PMID: 1930417
- DOI: 10.1016/0887-8994(91)90042-j
Timing of maintenance phenytoin therapy after intravenous loading dose
Abstract
The specific timing of maintenance phenytoin therapy in children has not been addressed. Prevention of a subtherapeutic phenytoin level is important for seizure control. We devised a protocol using an 18 mg/kg loading dose of phenytoin with serial levels (obtained after 2,6,12 hours) and analyzed the results in 20 consecutive patients. A therapeutic level (greater than 10 micrograms/ml) was present in all patients at 2 hours, in 16 of 20 at 6 hours, and in 10 of 20 at 12 hours. The patients were divided into 2 groups by the 12-hour levels: group I: therapeutic level; and group II: subtherapeutic level. The mean 2-hour level in group I was 22.7 micrograms/ml versus 15.6 micrograms/ml in group II (P less than 0.001). The mean decline in plasma concentration in individual patients was 0.7 micrograms/ml/hr in group I versus 1.02 micrograms/ml/hr in group II (P less than 0.05). We now use the 2-hour level to decide the timing of maintenance phenytoin therapy and have devised an equation to estimate the duration of the therapeutic range. Phenytoin can be administered at 12 hours when the 2-hour level is satisfactory or earlier when the 2-hour level indicates that a subtherapeutic level will occur.
Similar articles
-
Single-dose oral phenytoin loading.Ann Emerg Med. 1987 Apr;16(4):407-12. doi: 10.1016/s0196-0644(87)80360-8. Ann Emerg Med. 1987. PMID: 3826809 Clinical Trial.
-
An effective dose schedule for phenytoin treatment of status epilepticus in infancy and childhood.Neuropadiatrie. 1977 Aug;8(3):286-92. doi: 10.1055/s-0028-1091524. Neuropadiatrie. 1977. PMID: 578299
-
Kinetics of intravenous phenytoin in children.Pediatr Pharmacol (New York). 1984;4(1):31-8. Pediatr Pharmacol (New York). 1984. PMID: 6739185
-
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.Arch Intern Med. 1999 Dec 13-27;159(22):2639-44. doi: 10.1001/archinte.159.22.2639. Arch Intern Med. 1999. PMID: 10597754 Review.
-
Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.J Child Neurol. 1998 Oct;13 Suppl 1:S15-8; discussion S30-2. doi: 10.1177/0883073898013001051. J Child Neurol. 1998. PMID: 9796747 Review.
Cited by
-
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004. Clin Pharmacokinet. 1995. PMID: 8582119 Review.
-
Antiepileptic Drug Therapy for Status Epilepticus.J Clin Neurol. 2021 Jan;17(1):11-19. doi: 10.3988/jcn.2021.17.1.11. J Clin Neurol. 2021. PMID: 33480193 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical